Home - Products - GPCR/G Protein - Dopamine Receptor - Phenothiazine

Phenothiazine

CAS No. 92-84-2

Phenothiazine( Phenothiazine | NSC 2037 | NSC-2037 NSC2037 )

Catalog No. M16650 CAS No. 92-84-2

Phenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
500MG	38	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Phenothiazine
Note

Research use only, not for human use.
Brief Description

Phenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.
Description

Phenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.
In Vitro

——
In Vivo

——
Synonyms

Phenothiazine | NSC 2037 | NSC-2037 NSC2037
Pathway

GPCR/G Protein
Target

Dopamine Receptor
Recptor

Dopamine
Research Area

Neurological Disease
Indication

——

Chemical Information

CAS Number

92-84-2
Formula Weight

199.27
Molecular Formula

C12H9NS
Purity

>98% (HPLC)
Solubility

DMSO: 40 mg/mL (200.73 mM)
SMILES

C12=CC=CC=C1NC3=C(C=CC=C3)S2
Chemical Name

10H-Phenothiazine

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Pluta K, et al. Eur J Med Chem, 2011, 46(8), 3179-3189.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Tiospirone

Tiospirone (BMY 13859-1 free base) is a 5-HT2 receptor antagonist and dopamine blocker that inhibits D2, 5-HT1a, 5-HT7, and sigma receptors.
ONC206

ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??
Rotigotine (b)

Rotigotine is an antiparkinson agent and dopamine receptor agonist.

Sign In Join Free